In my view, I would just focus on the infectious diseases, hepatitis B and C. While I think they're important, I would think it was more efficient to screen people when they arrive. If somebody is just hepatitis B positive or hepatitis C positive on screening, I would not exclude them, unless they had serious liver disease in the country of origin. To ensure that they get treated so that they don't become an excessive burden on the health care system, my view is that the best way to do that would be to screen them on arrival in Canada.
If you screen them outside, and you don't exclude them when they arrive here, that test result—which might be done in a non-accredited lab, as we were talking about earlier—has to find its way all the way through the system to Canada, and then find its way to whichever primary care doctor that person ends up with. To my mind, those are very good reasons for having screening in Canada, and they're really important diseases. We did a burden of disease study in Ontario, and hepatitis B and C are right at the top of the list of things that are going to be a burden on public health.
I absolutely agree with you that they're vital, but I would do the screening in Canada.